Aquestive therapeutics to report fourth quarter 2022 financial results and recent business highlights on march 7 and host conference call on march 8 at 8:00 a.m. et

Warren, n.j., feb. 22, 2023 (globe newswire) -- aquestive therapeutics, inc. (nasdaq: aqst), (the “company” or “aquestive”), a pharmaceutical company advancing medicines to solve patients' problems with current standards of care and provide transformative products to improve their lives, today announced that it will report results for fourth quarter ended december 31, 2022, and provide an update on recent developments in its business after market close on tuesday, march 7, 2023.
AQST Ratings Summary
AQST Quant Ranking